71
53
Growth Score 71 in past quarter
-12 pts
Heat Score 53 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2568748
Sinopharm is the largest Chinese medical
Yao Fang: Chief SupervisorPast Role: Fosun Pharma, Team Member
About the Company
Sinopharm is the largest Chinese medical and healthcare group directly managed by State-owned Assets Supervision and Administration Commission of the State Council (SASAC), with the most complete industrial chain coverage and strongest comprehensive competence in China. Its core business includes distribution, retail, scientific research and
manufacture of healthcare-related products, and it owns 11 wholly-owned or holding subsidiaries and 6 listed companies.

